Dr. Campbell Discusses Advancements in Kidney Cancer Management

Steven Campbell, MD, PhD
Published: Tuesday, Aug 29, 2017



Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

The new guidelines for kidney cancer are extremely rich, says Campbell, which is a departure from the basic indexing that has been the standard since 2009.

The functional aspects of the evaluation and management of patients are emphasized in these new guidelines, explains Campbell, including recommendations on staging and who should be referred to the nephrologist.
 


Steven Campbell, MD, PhD, urologist, Cleveland Clinic, discusses recent advancements in the management of kidney cancer.

The new guidelines for kidney cancer are extremely rich, says Campbell, which is a departure from the basic indexing that has been the standard since 2009.

The functional aspects of the evaluation and management of patients are emphasized in these new guidelines, explains Campbell, including recommendations on staging and who should be referred to the nephrologist.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Moving Forward From the Status Quo for the Treatment of Soft Tissue Sarcoma: Key Questions & New Answers to Optimize OutcomesAug 16, 20181.5
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x